Sirio Pharma Co., Ltd. (300791.SZ)
Shantou, CN
Established in 1993 and headquartered in Shantou, China, Sirio Pharma Co., Ltd. serves as a global contract manufacturer. The company is dedicated to producing a broad spectrum of dietary supplements, encompassing traditional and vegetarian softgels, a wide range of nutraceutical gummies, probiotic formulations, tablets, powders, capsules, and functional beverages. Beyond manufacturing, Sirio Pharma also offers complete primary and final packaging solutions to its customers.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.66% | -3.05% | -7.18% | -17.69% | -22.12% | -30.01% | -20.37% | -4.38% | -43.22% | -48.33% | -48.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | +1 |
| Buy | 2 | -2 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+1.2% Q1'26: +5.1% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%-57.9% Q1'26: -44.8% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%-0.9% Q1'26: -11.3% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+2.3% Q1'26: +7.1% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+2.5% Q1'26: +5.7% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+30.8% Q1'26: +28.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×4.41× Q1'26: 6.02× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.07B
est: 2.11B (-2.0%)
|
2.37B
est: 2.37B (0.0%)
|
2.51B
est: 2.53B (-0.9%)
|
3.58B
est: 4.03B (-11.1%)
|
4.21B
est: 4.23B (-0.4%)
|
4.26B
est: 4.48B (-4.9%)
|
4.63B
4.62B – 4.65B
+3.3% YoY
|
5.19B
4.90B – 5.45B
+12.0% YoY
|
5.73B
5.72B – 5.73B
+10.4% YoY
|
| EBITDA |
353.57M
est: 332.90M (+6.2%)
|
379.29M
est: 374.09M (+1.4%)
|
366.95M
est: 399.57M (-8.2%)
|
597.06M
est: 565.21M (+5.6%)
|
612.03M
est: 593.50M (+3.1%)
|
354.56M
est: 629.18M (-43.6%)
|
649.99M
647.77M – 652.22M
+3.3% YoY
|
728.11M
688.10M – 764.34M
+12.0% YoY
|
803.93M
803.31M – 804.55M
+10.4% YoY
|
| EBIT |
273.85M
est: 233.96M (+17.0%)
|
281.11M
est: 262.91M (+6.9%)
|
242.59M
est: 280.82M (-13.6%)
|
376.33M
est: 358.56M (+5.0%)
|
429.20M
est: 376.51M (+14.0%)
|
96.84M
est: 399.14M (-75.7%)
|
412.34M
410.93M – 413.76M
+3.3% YoY
|
461.90M
436.52M – 484.89M
+12.0% YoY
|
510.00M
509.61M – 510.39M
+10.4% YoY
|
| Net Income |
257.37M
est: 325.47M (-20.9%)
|
231.83M
est: 301.33M (-23.1%)
|
212.29M
est: 181.76M (+16.8%)
|
281.04M
est: 436.25M (-35.6%)
|
325.06M
est: 331.71M (-2.0%)
|
136.53M
est: 209.15M (-34.7%)
|
351.92M
344.68M – 359.16M
+68.3% YoY
|
449.51M
412.99M – 486.03M
+27.7% YoY
|
558.00M
528.27M – 571.02M
+24.1% YoY
|
| SGA |
306.64M
est: 354.09M (-13.4%)
|
385.27M
est: 397.90M (-3.2%)
|
428.27M
est: 425.00M (+0.8%)
|
627.37M
est: 615.47M (+1.9%)
|
770.04M
est: 646.28M (+19.1%)
|
309.50M
est: 685.13M (-54.8%)
|
707.80M
705.37M – 710.22M
+3.3% YoY
|
792.86M
749.29M – 832.32M
+12.0% YoY
|
875.42M
874.75M – 876.10M
+10.4% YoY
|
| EPS |
1.43
est: 1.39 (+2.6%)
|
1.29
est: 1.29 (+0.0%)
|
1.18
est: 0.78 (+51.6%)
|
1.20
est: 1.43 (-16.1%)
|
1.07
est: 1.08 (-0.9%)
|
0.45
est: 0.69 (-34.4%)
|
1.15
1.13 – 1.18
+68.0% YoY
|
1.47
1.35 – 1.59
+27.9% YoY
|
1.80
1.73 – 1.87
+22.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 2/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 2/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 86.6K | 0.65% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 102.3K | 0.39% |
| 3 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 5.2K | 0.44% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 62.8K | 0.29% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 54.9K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fan Xia | Chief Financial Officer & Financial Director | — | female |
| Liqun Zheng | Deputy General Manager | — | female |
| Peiqing Li | GM & Chairman of the Board | — | male |
| Qiong Chen | Deputy GM & Director | — | female |
| Ruo Yang Liu | Board Secretary | — | — |
| Ya Song | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300791.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
